The FDA has approved tirzepatide – which will be sold under the brand name Zepbound – to treat overweight and obesity. It’s the latest entrant into a field of powerful new drugs that includes Ozempic and Wegovy.
Researchers have developed and tested a high-resolution sensor for tracking the real-time dynamics of adenosine triphosphate levels in cells and within subcellular compartments.
After sampling food markets in Chinatown districts, Cornell researchers found evidence that some threatened species of sea cucumbers – a pricey, nutritious delicacy – get sold to consumers.
Weill Cornell Medicine investigators have uncovered a way to unleash in blood vessels the protective effects of a type of fat-related molecule known as a sphingolipid, suggesting a promising new strategy for the treatment of coronary artery disease.
A simple blood test that measures the number of lymphocytes may predict whether people who have relapsed multiple myeloma are going to respond well to CAR-T immunotherapy.
Feuerstein has founded several digital health companies and is the executive director and founder of Yale School of Medicine’s Center for Digital Health and Innovation.
A new study provides evidence that a spillover of avian influenza from birds to dairy cattle across several U.S. states has now led to mammal-to-mammal transmission – between cows and from cows to cats and a raccoon.
